{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T18:56:45Z","timestamp":1781031405123,"version":"3.54.1"},"reference-count":168,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T00:00:00Z","timestamp":1715644800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T00:00:00Z","timestamp":1715644800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["5T34 GM149493-02"],"award-info":[{"award-number":["5T34 GM149493-02"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Exosomes are small extracellular vesicles (30\u2013150 nm) that are formed by endocytosis containing complex RNA as well as protein structures and are vital in intercellular communication and can be used in gene therapy and drug delivery. According to the cell sources of origin and the environmental conditions they are exposed to, these nanovesicles are very heterogeneous and dynamic in terms of content (cargo), size and membrane composition. Exosomes are released under physiological and pathological conditions and influence the pathogenesis of cancers through various mechanisms, including angiogenesis, metastasis, immune dysregulation, drug resistance, and tumor growth\/development. Gastrointestinal cancer is one of the deadliest types of cancer in humans and can involve organs e.g., the esophagus and stomach, or others such as the liver, pancreas, small intestine, and colon. Early diagnosis is very important in this field because the overall survival of patients is low due to diagnosis in late stages and recurrence. Also, various therapeutic strategies have failed and there is an unmet need for the new therapeutic agents. Exosomes can become promising candidates in gastrointestinal cancers as biomarkers and therapeutic agents due to their lower immunity and passing the main physiological barriers. In this work, we provide a general overview of exosomes, their biogenesis and biological functions. In addition, we discuss the potential of exosomes to serve as biomarkers, agents in cancer treatment, drug delivery systems, and effective vaccines in immunotherapy, with an emphasis on gastrointestinal cancers.<\/jats:p>\n                <jats:p><jats:bold>Graphical Abstract<\/jats:bold><\/jats:p>","DOI":"10.1007\/s12672-024-01024-x","type":"journal-article","created":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T04:17:00Z","timestamp":1715660220000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Harnessing exosomes in theranostic applications: advancements and insights in gastrointestinal cancer research"],"prefix":"10.1007","volume":"15","author":[{"given":"Ali","family":"Shojaeian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. R.","family":"Naeimi Torshizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahsa Sadat","family":"Parsapasand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra Sobhi","family":"Amjad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Khezrian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas","family":"Alibakhshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faye","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaveh","family":"Baghaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Razieh","family":"Amini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stevan","family":"Pecic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,14]]},"reference":[{"issue":"6478","key":"1024_CR1","doi-asserted-by":"publisher","DOI":"10.1126\/science.aau6977","volume":"367","author":"R Kalluri","year":"2020","unstructured":"Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020;367(6478): eaau6977.","journal-title":"Science"},{"issue":"5","key":"1024_CR2","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1182\/blood.V74.5.1844.1844","volume":"74","author":"RM Johnstone","year":"1989","unstructured":"Johnstone RM, Bianchini A, Teng K. Reticulocyte maturation and exosome release: transferrin receptor containing exosomes shows multiple plasma membrane functions. Blood. 1989;74(5):1844\u201351.","journal-title":"Blood"},{"issue":"2","key":"1024_CR3","doi-asserted-by":"publisher","first-page":"436","DOI":"10.3390\/jcm9020436","volume":"9","author":"M Tschuschke","year":"2020","unstructured":"Tschuschke M, Kocherova I, Bryja A, Mozdziak P, Angelova Volponi A, Janowicz K, et al. Inclusion biogenesis, methods of isolation and clinical application of human cellular exosomes. J Clin Med. 2020;9(2):436.","journal-title":"J Clin Med"},{"issue":"1","key":"1024_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13027-022-00471-x","volume":"17","author":"S Mahmoudvand","year":"2022","unstructured":"Mahmoudvand S, Shokri S, Nakhaie M, Jalilian FA, Mehri-Ghahfarrokhi A, Yarani R, Shojaeian A. Small extracellular vesicles as key players in cancer development caused by human oncogenic viruses. Infect Agents Cancer. 2022;17(1):1\u201316.","journal-title":"Infect Agents Cancer."},{"issue":"8","key":"1024_CR5","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.3390\/life12081143","volume":"12","author":"DN Kumar","year":"2022","unstructured":"Kumar DN, Chaudhuri A, Dehari D, Shekher A, Gupta SC, Majumdar S, et al. Combination therapy comprising paclitaxel and 5-fluorouracil by using folic acid functionalized bovine milk exosomes improves the therapeutic efficacy against breast cancer. Life. 2022;12(8):1143.","journal-title":"Life"},{"issue":"3","key":"1024_CR6","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.3390\/ijms22031105","volume":"22","author":"L del Pozo-Acebo","year":"2021","unstructured":"del Pozo-Acebo L, L\u00f3pez de las Hazas M, Tom\u00e9-Carneiro J, Gil-Cabrerizo P, San-Cristobal R, Busto R, et al. Bovine milk-derived exosomes as a drug delivery vehicle for miRNA-based therapy. Int J Mol Sci. 2021;22(3):1105.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"1024_CR7","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1172\/JCI81135","volume":"126","author":"R Kalluri","year":"2016","unstructured":"Kalluri R. The biology and function of exosomes in cancer. J Clin Investig. 2016;126(4):1208\u201315.","journal-title":"J Clin Investig"},{"issue":"9","key":"1024_CR8","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1016\/j.apsb.2021.01.001","volume":"11","author":"J Liu","year":"2021","unstructured":"Liu J, Ren L, Li S, Li W, Zheng X, Yang Y, et al. The biology, function, and applications of exosomes in cancer. Acta Pharmaceutica Sinica B. 2021;11(9):2783\u201397.","journal-title":"Acta Pharmaceutica Sinica B."},{"issue":"51","key":"1024_CR9","doi-asserted-by":"publisher","first-page":"2002440","DOI":"10.1002\/adma.202002440","volume":"32","author":"GH Nam","year":"2020","unstructured":"Nam GH, Choi Y, Kim GB, Kim S, Kim SA, Kim IS. Emerging prospects of exosomes for cancer treatment: from conventional therapy to immunotherapy. Adv Mater. 2020;32(51):2002440.","journal-title":"Adv Mater"},{"issue":"3","key":"1024_CR10","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.addr.2012.06.014","volume":"65","author":"A Tan","year":"2013","unstructured":"Tan A, Rajadas J, Seifalian AM. Exosomes as nano-theranostic delivery platforms for gene therapy. Adv Drug Deliv Rev. 2013;65(3):357\u201367.","journal-title":"Adv Drug Deliv Rev"},{"issue":"10","key":"1024_CR11","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.4155\/fmc-2018-0417","volume":"11","author":"W Whitford","year":"2019","unstructured":"Whitford W, Guterstam P. Exosome manufacturing status. Future Med Chem. 2019;11(10):1225\u201336.","journal-title":"Future Med Chem"},{"key":"1024_CR12","unstructured":"Hou H, Tian Z, Zhang W. Application of exosomes as markers and drug carriers in tumors."},{"key":"1024_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.705999","volume":"12","author":"D-K Wang","year":"2021","unstructured":"Wang D-K, Zuo Q, He Q-Y, Li B. Targeted immunotherapies in gastrointestinal cancer: from molecular mechanisms to implications. Front Immunol. 2021;12: 705999.","journal-title":"Front Immunol"},{"issue":"1","key":"1024_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-021-01396-6","volume":"20","author":"X-H Tang","year":"2021","unstructured":"Tang X-H, Guo T, Gao X-Y, Wu X-L, Xing X-F, Ji J-F, Li Z-Y. Exosome-derived noncoding RNAs in gastric cancer: functions and clinical applications. Mol Cancer. 2021;20(1):1\u201315.","journal-title":"Mol Cancer"},{"issue":"1","key":"1024_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-017-0706-8","volume":"16","author":"W Li","year":"2017","unstructured":"Li W, Li C, Zhou T, Liu X, Liu X, Li X, Chen D. Role of exosomal proteins in cancer diagnosis. Mol Cancer. 2017;16(1):1\u201312.","journal-title":"Mol Cancer"},{"issue":"8","key":"1024_CR16","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1007\/s00423-016-1468-2","volume":"401","author":"M Rahbari","year":"2016","unstructured":"Rahbari M, Rahbari N, Reissfelder C, Weitz J, Kahlert C. Exosomes: novel implications in diagnosis and treatment of gastrointestinal cancer. Langenbecks Arch Surg. 2016;401(8):1097\u2013110.","journal-title":"Langenbecks Arch Surg"},{"issue":"4","key":"1024_CR17","doi-asserted-by":"publisher","first-page":"310","DOI":"10.3390\/medicines2040310","volume":"2","author":"P Munson","year":"2015","unstructured":"Munson P, Shukla A. Exosomes: potential in cancer diagnosis and therapy. Medicines. 2015;2(4):310\u201327.","journal-title":"Medicines"},{"issue":"11","key":"1024_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-019-2077-0","volume":"10","author":"Z-X Liang","year":"2019","unstructured":"Liang Z-X, Liu H-S, Wang F-W, Xiong L, Zhou C, Hu T, et al. LncRNA RPPH1 promotes colorectal cancer metastasis by interacting with TUBB3 and by promoting exosomes-mediated macrophage M2 polarization. Cell Death Disease. 2019;10(11):1\u201317.","journal-title":"Cell Death Disease."},{"issue":"2","key":"1024_CR19","first-page":"3313","volume":"10","author":"H Liu","year":"2017","unstructured":"Liu H, Yang Z, Zhang J, Zhu X. MicroRNA-217 in plasma: a potential biomarker in gastric cancer. Int J Clin Exp Med. 2017;10(2):3313\u201320.","journal-title":"Int J Clin Exp Med"},{"issue":"10","key":"1024_CR20","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.3390\/life11101044","volume":"11","author":"Y Wang","year":"2021","unstructured":"Wang Y, Zhao R, Jiao X, Wu L, Wei Y, Shi F, et al. Small extracellular vesicles: functions and potential clinical applications as cancer biomarkers. Life. 2021;11(10):1044.","journal-title":"Life"},{"issue":"2","key":"1024_CR21","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s00018-017-2595-9","volume":"75","author":"NP Hessvik","year":"2018","unstructured":"Hessvik NP, Llorente A. Current knowledge on exosome biogenesis and release. Cell Mol Life Sci. 2018;75(2):193\u2013208.","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"1024_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-020-01278-3","volume":"19","author":"Z Xu","year":"2020","unstructured":"Xu Z, Zeng S, Gong Z, Yan Y. Exosome-based immunotherapy: a promising approach for cancer treatment. Mol Cancer. 2020;19(1):1\u201316.","journal-title":"Mol Cancer"},{"issue":"2","key":"1024_CR23","doi-asserted-by":"publisher","first-page":"665","DOI":"10.3892\/or.2017.5714","volume":"38","author":"W Guo","year":"2017","unstructured":"Guo W, Gao Y, Li N, Shao F, Wang C, Wang P, et al. Exosomes: new players in cancer. Oncol Rep. 2017;38(2):665\u201375.","journal-title":"Oncol Rep"},{"issue":"7","key":"1024_CR24","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1111\/j.1600-0854.2009.00920.x","volume":"10","author":"S Stuffers","year":"2009","unstructured":"Stuffers S, Sem Wegner C, Stenmark H, Brech A. Multivesicular endosome biogenesis in the absence of ESCRTs. Traffic. 2009;10(7):925\u201337.","journal-title":"Traffic"},{"issue":"6","key":"1024_CR25","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1016\/j.bpj.2017.05.032","volume":"113","author":"CE Jackson","year":"2017","unstructured":"Jackson CE, Scruggs BS, Schaffer JE, Hanson PI. Effects of inhibiting VPS4 support a general role for ESCRTs in extracellular vesicle biogenesis. Biophys J. 2017;113(6):1342\u201352.","journal-title":"Biophys J"},{"issue":"1","key":"1024_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12964-021-00730-1","volume":"19","author":"S Gurung","year":"2021","unstructured":"Gurung S, Perocheau D, Touramanidou L, Baruteau J. The exosome journey: from biogenesis to uptake and intracellular signalling. Cell Commun Signal. 2021;19(1):1\u201319.","journal-title":"Cell Commun Signal"},{"issue":"1","key":"1024_CR27","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.devcel.2010.12.003","volume":"20","author":"R Sahu","year":"2011","unstructured":"Sahu R, Kaushik S, Clement CC, Cannizzo ES, Scharf B, Follenzi A, et al. Microautophagy of cytosolic proteins by late endosomes. Dev Cell. 2011;20(1):131\u20139.","journal-title":"Dev Cell"},{"key":"1024_CR28","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1146\/annurev-cellbio-092910-154152","volume":"28","author":"PI Hanson","year":"2012","unstructured":"Hanson PI, Cashikar A. Multivesicular body morphogenesis. Annu Rev Cell Dev Biol. 2012;28:337\u201362.","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"2","key":"1024_CR29","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/tra.12139","volume":"15","author":"JR Edgar","year":"2014","unstructured":"Edgar JR, Eden ER, Futter CE. Hrs-and CD63-dependent competing mechanisms make different sized endosomal intraluminal vesicles. Traffic. 2014;15(2):197\u2013211.","journal-title":"Traffic"},{"key":"1024_CR30","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.canlet.2018.07.037","volume":"435","author":"X Li","year":"2018","unstructured":"Li X, Wang Y, Wang Q, Liu Y, Bao W, Wu S. Exosomes in cancer: small transporters with big functions. Cancer Lett. 2018;435:55\u201365.","journal-title":"Cancer Lett"},{"key":"1024_CR31","doi-asserted-by":"publisher","first-page":"533","DOI":"10.3389\/fphar.2016.00533","volume":"7","author":"J Wang","year":"2017","unstructured":"Wang J, Zheng Y, Zhao M. Exosome-based cancer therapy: implication for targeting cancer stem cells. Front Pharmacol. 2017;7:533.","journal-title":"Front Pharmacol"},{"issue":"1","key":"1024_CR32","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12943-021-01396-6","volume":"20","author":"XH Tang","year":"2021","unstructured":"Tang XH, Guo T, Gao XY, Wu XL, Xing XF, Ji JF, Li ZY. Exosome-derived noncoding RNAs in gastric cancer: functions and clinical applications. Mol Cancer. 2021;20(1):99.","journal-title":"Mol Cancer"},{"key":"1024_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.756205","volume":"11","author":"L Li","year":"2021","unstructured":"Li L, Zhao J, Zhang Q, Tao Y, Shen C, Li R, et al. Cancer cell-derived exosomes promote HCC tumorigenesis through hedgehog pathway. Front Oncol. 2021;11: 756205.","journal-title":"Front Oncol"},{"key":"1024_CR34","first-page":"1","volume":"2022","author":"Y Li","year":"2022","unstructured":"Li Y, Meng L, Li B, Li Y, Shen T, Zhao B. The exosome journey: from biogenesis to regulation and function in cancers. J Oncol. 2022;2022:1\u201313.","journal-title":"J Oncol"},{"issue":"3","key":"1024_CR35","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1039\/D0NR07622H","volume":"13","author":"L Duan","year":"2021","unstructured":"Duan L, Xu L, Xu X, Qin Z, Zhou X, Xiao Y, et al. Exosome-mediated delivery of gene vectors for gene therapy. Nanoscale. 2021;13(3):1387\u201397.","journal-title":"Nanoscale"},{"issue":"6","key":"1024_CR36","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1002\/wrna.1363","volume":"7","author":"Y Zhou","year":"2016","unstructured":"Zhou Y, Zhou G, Tian C, Jiang W, Jin L, Zhang C, Chen X. Exosome-mediated small RNA delivery for gene therapy. Wiley Interdiscip Rev RNA. 2016;7(6):758\u201371.","journal-title":"Wiley Interdiscip Rev RNA."},{"issue":"4","key":"1024_CR37","first-page":"537","volume":"71","author":"J Qin","year":"2014","unstructured":"Qin J, Xu Q. Functions and application of exosomes. Acta Pol Pharm. 2014;71(4):537\u201343.","journal-title":"Acta Pol Pharm"},{"issue":"4","key":"1024_CR38","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.apsb.2016.02.001","volume":"6","author":"D Ha","year":"2016","unstructured":"Ha D, Yang N, Nadithe V. Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: current perspectives and future challenges. Acta Pharmaceutica Sinica B. 2016;6(4):287\u201396.","journal-title":"Acta Pharmaceutica Sinica B."},{"key":"1024_CR39","doi-asserted-by":"publisher","first-page":"4161","DOI":"10.2147\/OTT.S143315","volume":"10","author":"M Ma","year":"2017","unstructured":"Ma M, Chen S, Liu Z, Xie H, Deng H, Shang S, et al. miRNA-221 of exosomes originating from bone marrow mesenchymal stem cells promotes oncogenic activity in gastric cancer. OncoTargets Thera. 2017;10:4161\u201371.","journal-title":"OncoTargets Thera."},{"key":"1024_CR40","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/bs.acc.2015.12.005","volume":"74","author":"TL Whiteside","year":"2016","unstructured":"Whiteside TL. Tumor-derived exosomes and their role in cancer progression. Adv Clin Chem. 2016;74:103\u201341.","journal-title":"Adv Clin Chem"},{"key":"1024_CR41","doi-asserted-by":"publisher","first-page":"3363","DOI":"10.2147\/IJN.S240660","volume":"15","author":"L Wang","year":"2020","unstructured":"Wang L, Zhang J. Exosomal lncRNA AK139128 derived from hypoxic cardiomyocytes promotes apoptosis and inhibits cell proliferation in cardiac fibroblasts. Int J Nanomed. 2020;15:3363\u201376.","journal-title":"Int J Nanomed"},{"issue":"1","key":"1024_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13045-015-0181-x","volume":"8","author":"X Zhang","year":"2015","unstructured":"Zhang X, Yuan X, Shi H, Wu L, Qian H, Xu W. Exosomes in cancer: small particle, big player. J Hematol Oncol. 2015;8(1):1\u201313.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"1024_CR43","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13027-022-00471-x","volume":"17","author":"S Mahmoudvand","year":"2022","unstructured":"Mahmoudvand S, Shokri S, Nakhaie M, Jalilian FA, Mehri-Ghahfarrokhi A, Yarani R, Shojaeian A. Small extracellular vesicles as key players in cancer development caused by human oncogenic viruses. Infect Agents Cancer. 2022;17(1):58.","journal-title":"Infect Agents Cancer."},{"issue":"1","key":"1024_CR44","doi-asserted-by":"publisher","first-page":"1722385","DOI":"10.1080\/20013078.2020.1722385","volume":"9","author":"Y Lin","year":"2020","unstructured":"Lin Y, Zhang C, Xiang P, Shen J, Sun W, Yu H. Exosomes derived from HeLa cells break down vascular integrity by triggering endoplasmic reticulum stress in endothelial cells. J Extracell Vesicles. 2020;9(1):1722385.","journal-title":"J Extracell Vesicles."},{"issue":"17","key":"1024_CR45","doi-asserted-by":"publisher","first-page":"3513","DOI":"10.1038\/emboj.2012.183","volume":"31","author":"G Zhuang","year":"2012","unstructured":"Zhuang G, Wu X, Jiang Z, Kasman I, Yao J, Guan Y, et al. Tumour-secreted miR-9 promotes endothelial cell migration and angiogenesis by activating the JAK-STAT pathway. EMBO J. 2012;31(17):3513\u201323.","journal-title":"EMBO J"},{"issue":"2","key":"1024_CR46","first-page":"455","volume":"1871","author":"L Zhang","year":"2019","unstructured":"Zhang L, Yu D. Exosomes in cancer development, metastasis, and immunity. Biochim Biophys Acta. 2019;1871(2):455\u201368.","journal-title":"Biochim Biophys Acta"},{"issue":"8","key":"1024_CR47","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1593\/neo.13786","volume":"15","author":"W Mu","year":"2013","unstructured":"Mu W, Rana S, Z\u00f6ller M. Host matrix modulation by tumor exosomes promotes motility and invasiveness. Neoplasia. 2013;15(8):875.","journal-title":"Neoplasia"},{"issue":"6","key":"1024_CR48","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/nrc3747","volume":"14","author":"I Lokody","year":"2014","unstructured":"Lokody I. Exosomally derived miR-105 destroys tight junctions. Nat Rev Cancer. 2014;14(6):386\u20137.","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"1024_CR49","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.ccr.2014.03.007","volume":"25","author":"W Zhou","year":"2014","unstructured":"Zhou W, Fong MY, Min Y, Somlo G, Liu L, Palomares MR, et al. Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis. Cancer Cell. 2014;25(4):501\u201315.","journal-title":"Cancer Cell"},{"key":"1024_CR50","doi-asserted-by":"publisher","first-page":"361","DOI":"10.3389\/fonc.2014.00361","volume":"4","author":"LJ Vella","year":"2014","unstructured":"Vella LJ. The emerging role of exosomes in epithelial\u2013mesenchymal-transition in cancer. Front Oncol. 2014;4:361.","journal-title":"Front Oncol"},{"issue":"3","key":"1024_CR51","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1158\/0008-5472.CAN-16-0964","volume":"77","author":"M Tanaka","year":"2017","unstructured":"Tanaka M, Kuriyama S, Itoh G, Maeda D, Goto A, Tamiya Y, et al. Mesothelial cells create a novel tissue niche that facilitates gastric cancer invasion. Can Res. 2017;77(3):684\u201395.","journal-title":"Can Res"},{"key":"1024_CR52","first-page":"2718","volume":"21","author":"W Liu","year":"2015","unstructured":"Liu W, Song N, Yao H, Zhao L, Liu H, Li G. miR-221 and miR-222 simultaneously target RECK and regulate growth and invasion of gastric cancer Cells. Med Sci Monit Int Med J Exp Clin Res. 2015;21:2718\u201325.","journal-title":"Med Sci Monit Int Med J Exp Clin Res."},{"issue":"6","key":"1024_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/ijmm.2021.4945","volume":"47","author":"JMC Danac","year":"2021","unstructured":"Danac JMC, Uy AGG, Garcia RL. Exosomal microRNAs in colorectal cancer: overcoming barriers of the metastatic cascade (Review). Int J Mol Med. 2021;47(6):1\u201316.","journal-title":"Int J Mol Med"},{"issue":"1","key":"1024_CR54","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3892\/ijmm.2022.5206","volume":"51","author":"N Thapa","year":"2023","unstructured":"Thapa N, Chwae YJ, Yoo KH, Won T-B, Kang D, Choi D, Kim J. Exosomal delivery of TRAIL and miR-335 for the treatment of hepatocellular carcinoma (review). Int J Mol Med. 2023;51(1):3.","journal-title":"Int J Mol Med"},{"issue":"17","key":"1024_CR55","doi-asserted-by":"publisher","first-page":"9512","DOI":"10.3390\/ijms23179512","volume":"23","author":"X Chu","year":"2022","unstructured":"Chu X, Yang Y, Tian X. Crosstalk between pancreatic cancer cells and cancer-associated fibroblasts in the tumor microenvironment mediated by exosomal MicroRNAs. Int J Mol Sci. 2022;23(17):9512.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"1024_CR56","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1111\/j.1600-0854.2011.01225.x","volume":"12","author":"A Bobrie","year":"2011","unstructured":"Bobrie A, Colombo M, Raposo G, Th\u00e9ry C. Exosome secretion: molecular mechanisms and roles in immune responses. Traffic. 2011;12(12):1659\u201368.","journal-title":"Traffic"},{"issue":"8","key":"1024_CR57","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/nri855","volume":"2","author":"C Th\u00e9ry","year":"2002","unstructured":"Th\u00e9ry C, Zitvogel L, Amigorena S. Exosomes: composition, biogenesis and function. Nat Rev Immunol. 2002;2(8):569\u201379.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"1024_CR58","doi-asserted-by":"publisher","first-page":"367","DOI":"10.3390\/ijms21010367","volume":"21","author":"MP Scavo","year":"2020","unstructured":"Scavo MP, Depalo N, Tutino V, De Nunzio V, Ingrosso C, Rizzi F, et al. Exosomes for diagnosis and therapy in gastrointestinal cancers. Int J Mol Sci. 2020;21(1):367.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1024_CR59","doi-asserted-by":"publisher","DOI":"10.1186\/s40169-018-0192-7","volume":"7","author":"RE Lane","year":"2018","unstructured":"Lane RE, Korbie D, Hill MM, Trau M. Extracellular vesicles as circulating cancer biomarkers: opportunities and challenges. Clin Transl Med. 2018;7(1): e14.","journal-title":"Clin Transl Med"},{"issue":"2","key":"1024_CR60","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/j.1538-7836.2009.03654.x","volume":"8","author":"Y Yuana","year":"2010","unstructured":"Yuana Y, Oosterkamp TH, Bahatyrova S, Ashcroft B, Garcia Rodriguez P, Bertina RM, Osanto S. Atomic force microscopy: a novel approach to the detection of nanosized blood microparticles. J Thromb Haemostasis JTH. 2010;8(2):315\u201323.","journal-title":"J Thromb Haemostasis JTH."},{"issue":"1","key":"1024_CR61","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s13045-017-0542-8","volume":"10","author":"A Li","year":"2017","unstructured":"Li A, Zhang T, Zheng M, Liu Y, Chen Z. Exosomal proteins as potential markers of tumor diagnosis. J Hematol Oncol. 2017;10(1):175.","journal-title":"J Hematol Oncol"},{"issue":"6","key":"1024_CR62","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/ncb3169","volume":"17","author":"B Costa-Silva","year":"2015","unstructured":"Costa-Silva B, Aiello NM, Ocean AJ, Singh S, Zhang H, Thakur Basant K, et al. Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver. Nat Cell Biol. 2015;17(6):816\u201326.","journal-title":"Nat Cell Biol"},{"issue":"5\u20136","key":"1024_CR63","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1159\/000107106","volume":"71","author":"M Notarnicola","year":"2006","unstructured":"Notarnicola M, Altomare DF, Calvani M, Orlando A, Bifulco M, D\u2019Attoma B, Caruso MG. Fatty acid synthase hyperactivation in human colorectal cancer: relationship with tumor side and sex. Oncology. 2006;71(5\u20136):327\u201332.","journal-title":"Oncology"},{"issue":"7","key":"1024_CR64","first-page":"2585","volume":"32","author":"M Notarnicola","year":"2012","unstructured":"Notarnicola M, Messa C, Caruso MG. A significant role of lipogenic enzymes in colorectal cancer. Anticancer Res. 2012;32(7):2585.","journal-title":"Anticancer Res"},{"issue":"2","key":"1024_CR65","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1002\/path.1760","volume":"206","author":"T Van de Sande","year":"2005","unstructured":"Van de Sande T, Roskams T, Lerut E, Joniau S, Van Poppel H, Verhoeven G, Swinnen JV. High-level expression of fatty acid synthase in human prostate cancer tissues is linked to activation and nuclear localization of Akt\/PKB. J Pathol. 2005;206(2):214\u20139.","journal-title":"J Pathol"},{"issue":"5","key":"1024_CR66","doi-asserted-by":"publisher","first-page":"101042831984861","DOI":"10.1177\/1010428319848616","volume":"41","author":"C Kitamura","year":"2019","unstructured":"Kitamura C, Sonoda H, Nozawa H, Kano K, Emoto S, Murono K, et al. The component changes of lysophospholipid mediators in colorectal cancer. Tumor Biology. 2019;41(5):1010428319848616.","journal-title":"Tumor Biology."},{"key":"1024_CR67","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/978-3-0348-0837-8_2","volume":"816","author":"NB Janakiram","year":"2014","unstructured":"Janakiram NB, Rao CV. The role of inflammation in colon cancer. Adv Exp Med Biol. 2014;816:25\u201352.","journal-title":"Adv Exp Med Biol"},{"issue":"9","key":"1024_CR68","first-page":"4775","volume":"34","author":"G Coviello","year":"2014","unstructured":"Coviello G, Tutino V, Notarnicola M, Caruso MG. Erythrocyte membrane fatty acids profile in colorectal cancer patients: a preliminary study. Anticancer Res. 2014;34(9):4775\u20139.","journal-title":"Anticancer Res"},{"issue":"4","key":"1024_CR69","doi-asserted-by":"publisher","first-page":"962","DOI":"10.3390\/ijms19040962","volume":"19","author":"M Notarnicola","year":"2018","unstructured":"Notarnicola M, Lorusso D, Tutino V, De Nunzio V, De Leonardis G, Marangelli G, et al. Differential tissue fatty acids profiling between colorectal cancer patients with and without synchronous metastasis. Int J Mol Sci. 2018;19(4):962.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1024_CR70","doi-asserted-by":"publisher","first-page":"32570","DOI":"10.3402\/jev.v5.32570","volume":"5","author":"RA Haraszti","year":"2016","unstructured":"Haraszti RA, Didiot M-C, Sapp E, Leszyk J, Shaffer SA, Rockwell HE, et al. High-resolution proteomic and lipidomic analysis of exosomes and microvesicles from different cell sources. J Extracell Vesicles. 2016;5(1):32570.","journal-title":"J Extracell Vesicles."},{"issue":"1","key":"1024_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7150\/ijbs.27796","volume":"15","author":"T Huang","year":"2019","unstructured":"Huang T, Deng C-X. Current progresses of exosomes as cancer diagnostic and prognostic biomarkers. Int J Biol Sci. 2019;15(1):1\u201311.","journal-title":"Int J Biol Sci"},{"issue":"3","key":"1024_CR72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-019-0219-1","volume":"51","author":"N Kosaka","year":"2019","unstructured":"Kosaka N, Kogure A, Yamamoto T, Urabe F, Usuba W, Prieto-Vila M, Ochiya T. Exploiting the message from cancer: the diagnostic value of extracellular vesicles for clinical applications. Exp Mol Med. 2019;51(3):1\u20139.","journal-title":"Exp Mol Med"},{"key":"1024_CR73","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.plipres.2017.03.001","volume":"66","author":"T Skotland","year":"2017","unstructured":"Skotland T, Sandvig K, Llorente A. Lipids in exosomes: current knowledge and the way forward. Prog Lipid Res. 2017;66:30\u201341.","journal-title":"Prog Lipid Res"},{"issue":"1","key":"1024_CR74","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2016.153","volume":"49","author":"M Tomasetti","year":"2017","unstructured":"Tomasetti M, Lee W, Santarelli L, Neuzil J. Exosome-derived microRNAs in cancer metabolism: possible implications in cancer diagnostics and therapy. Exp Mol Med. 2017;49(1): e285.","journal-title":"Exp Mol Med"},{"issue":"4","key":"1024_CR75","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.bulcan.2017.12.009","volume":"105","author":"G Dai","year":"2018","unstructured":"Dai G, Yao X, Zhang Y, Gu J, Geng Y, Xue F, Zhang J. Colorectal cancer cell\u2013derived exosomes containing miR-10b regulate fibroblast cells via the PI3K\/Akt pathway. Bull Cancer. 2018;105(4):336\u201349.","journal-title":"Bull Cancer"},{"issue":"1","key":"1024_CR76","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s12943-018-0863-4","volume":"17","author":"M Herrera","year":"2018","unstructured":"Herrera M, Llorens C, Rodr\u00edguez M, Herrera A, Ramos R, Gil B, et al. Differential distribution and enrichment of non-coding RNAs in exosomes from normal and cancer-associated fibroblasts in colorectal cancer. Mol Cancer. 2018;17(1):114.","journal-title":"Mol Cancer"},{"issue":"3","key":"1024_CR77","doi-asserted-by":"publisher","first-page":"533","DOI":"10.21147\/j.issn.1000-9604.2019.03.15","volume":"31","author":"QZL Ju","year":"2019","unstructured":"Ju QZL, Gao J, Zhou L, Xu Y, Sun Y, Zhao X. Mutant p53 increases exosome-mediated transfer of miR-21-3p and miR-769-3p to promote pulmonary metastasis. Chin J Cancer Res. 2019;31(3):533\u201346.","journal-title":"Chin J Cancer Res"},{"issue":"1","key":"1024_CR78","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/s41467-018-03224-w","volume":"9","author":"T Cooks","year":"2018","unstructured":"Cooks T, Pateras IS, Jenkins LM, Patel KM, Robles AI, Morris J, et al. Mutant p53 cancers reprogram macrophages to tumor supporting macrophages via exosomal miR-1246. Nat Commun. 2018;9(1):771.","journal-title":"Nat Commun"},{"issue":"1","key":"1024_CR79","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1186\/s13046-018-0965-2","volume":"37","author":"Y Zhou","year":"2018","unstructured":"Zhou Y, Ren H, Dai B, Li J, Shang L, Huang J, Shi X. Hepatocellular carcinoma-derived exosomal miRNA-21 contributes to tumor progression by converting hepatocyte stellate cells to cancer-associated fibroblasts. J Exp Clin Cancer Res. 2018;37(1):324.","journal-title":"J Exp Clin Cancer Res"},{"issue":"37","key":"1024_CR80","doi-asserted-by":"publisher","first-page":"59173","DOI":"10.18632\/oncotarget.10384","volume":"7","author":"A Gutkin","year":"2016","unstructured":"Gutkin A, Uziel O, Beery E, Nordenberg J, Pinchasi M, Goldvaser H, et al. Tumor cells derived exosomes contain hTERT mRNA and transform nonmalignant fibroblasts into telomerase positive cells. Oncotarget. 2016;7(37):59173.","journal-title":"Oncotarget"},{"issue":"1","key":"1024_CR81","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13046-017-0528-y","volume":"36","author":"P Zheng","year":"2017","unstructured":"Zheng P, Chen L, Yuan X, Luo Q, Liu Y, Xie G, et al. Exosomal transfer of tumor-associated macrophage-derived miR-21 confers cisplatin resistance in gastric cancer cells. J Exp Clin Cancer Res. 2017;36(1):53.","journal-title":"J Exp Clin Cancer Res"},{"issue":"6","key":"1024_CR82","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1007\/s00432-017-2361-2","volume":"143","author":"L Pan","year":"2017","unstructured":"Pan L, Liang W, Fu M, Huang Z-H, Li X, Zhang W, et al. Exosomes-mediated transfer of long noncoding RNA ZFAS1 promotes gastric cancer progression. J Cancer Res Clin Oncol. 2017;143(6):991\u20131004.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"6","key":"1024_CR83","doi-asserted-by":"publisher","first-page":"798","DOI":"10.3390\/cancers11060798","volume":"11","author":"CRV Melzer","year":"2019","unstructured":"Melzer CRV, Yang Y, B\u00e4hre H, von der Ohe J, Hass R. Taxol-loaded MSC-derived exosomes provide a therapeutic vehicle to target metastatic breast cancer and other carcinoma cells. Cancers. 2019;11(6):798.","journal-title":"Cancers"},{"issue":"22","key":"1024_CR84","doi-asserted-by":"publisher","first-page":"12204","DOI":"10.3390\/ijms222212204","volume":"22","author":"Y Zhou","year":"2021","unstructured":"Zhou Y, Zhang Y, Gong H, Luo S, Cui Y. The role of exosomes and their applications in cancer. Int J Mol Sci. 2021;22(22):12204.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"1024_CR85","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.tibtech.2017.03.004","volume":"35","author":"NL Syn","year":"2017","unstructured":"Syn NL, Wang L, Chow EK-H, Lim CT, Goh B-C. Exosomes in cancer nanomedicine and immunotherapy: prospects and challenges. Trends Biotechnol. 2017;35(7):665\u201376.","journal-title":"Trends Biotechnol"},{"issue":"34","key":"1024_CR86","doi-asserted-by":"publisher","first-page":"4224","DOI":"10.2174\/0929867324666170830113755","volume":"25","author":"S Palazzolo","year":"2018","unstructured":"Palazzolo S, Bayda S, Hadla M, Caligiuri I, Corona G, Toffoli G, Rizzolio F. The clinical translation of organic nanomaterials for cancer therapy: a focus on polymeric nanoparticles, micelles, liposomes and exosomes. Curr Med Chem. 2018;25(34):4224\u201368.","journal-title":"Curr Med Chem"},{"issue":"6","key":"1024_CR87","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/j.copbio.2013.02.020","volume":"24","author":"LY Rizzo","year":"2013","unstructured":"Rizzo LY, Theek B, Storm G, Kiessling F, Lammers T. Recent progress in nanomedicine: therapeutic, diagnostic and theranostic applications. Curr Opin Biotechnol. 2013;24(6):1159\u201366.","journal-title":"Curr Opin Biotechnol"},{"issue":"10","key":"1024_CR88","doi-asserted-by":"publisher","first-page":"3173","DOI":"10.1111\/cas.14181","volume":"110","author":"M Yu","year":"2019","unstructured":"Yu M, Gai C, Li Z, Ding D, Zheng J, Zhang W, et al. Targeted exosome-encapsulated erastin induced ferroptosis in triple negative breast cancer cells. Cancer Sci. 2019;110(10):3173\u201382.","journal-title":"Cancer Sci"},{"issue":"18","key":"1024_CR89","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.2217\/nnm-2016-0154","volume":"11","author":"M Hadla","year":"2016","unstructured":"Hadla M, Palazzolo S, Corona G, Caligiuri I, Canzonieri V, Toffoli G, Rizzolio F. Exosomes increase the therapeutic index of doxorubicin in breast and ovarian cancer mouse models. Nanomedicine (Lond). 2016;11(18):2431\u201341.","journal-title":"Nanomedicine (Lond)"},{"key":"1024_CR90","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.jconrel.2014.07.042","volume":"192","author":"L Pascucci","year":"2014","unstructured":"Pascucci L, Cocc\u00e8 V, Bonomi A, Ami D, Ceccarelli P, Ciusani E, et al. Paclitaxel is incorporated by mesenchymal stromal cells and released in exosomes that inhibit in vitro tumor growth: a new approach for drug delivery. J Controlled Release. 2014;192:262\u201370.","journal-title":"J Controlled Release."},{"issue":"3","key":"1024_CR91","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.ymthe.2018.01.001","volume":"26","author":"X Wang","year":"2018","unstructured":"Wang X, Zhang H, Bai M, Ning T, Ge S, Deng T, et al. Exosomes serve as nanoparticles to deliver anti-miR-214 to reverse chemoresistance to cisplatin in gastric cancer. Mol Ther. 2018;26(3):774\u201383.","journal-title":"Mol Ther"},{"key":"1024_CR92","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.jconrel.2018.04.037","volume":"279","author":"E Cho","year":"2018","unstructured":"Cho E, Nam GH, Hong Y, Kim YK, Kim DH, Yang Y, Kim IS. Comparison of exosomes and ferritin protein nanocages for the delivery of membrane protein therapeutics. J Controlled Release. 2018;279:326\u201335.","journal-title":"J Controlled Release"},{"issue":"7","key":"1024_CR93","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1016\/j.nano.2018.05.020","volume":"14","author":"Y Li","year":"2018","unstructured":"Li Y, Gao Y, Gong C, Wang Z, Xia Q, Gu F, et al. A33 antibody-functionalized exosomes for targeted delivery of doxorubicin against colorectal cancer. Nanomed Nanotechnol Biol Med. 2018;14(7):1973\u201385.","journal-title":"Nanomed Nanotechnol Biol Med"},{"key":"1024_CR94","first-page":"765","volume":"6","author":"JJ Wang","year":"2011","unstructured":"Wang JJ, Zeng ZW, Xiao RZ, Xie T, Zhou GL, Zhan XR, Wang SL. Recent advances of chitosan nanoparticles as drug carriers. Int J Nanomed. 2011;6:765.","journal-title":"Int J Nanomed"},{"issue":"1\u20132","key":"1024_CR95","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ijpharm.2017.02.038","volume":"521","author":"X-C Jiang","year":"2017","unstructured":"Jiang X-C, Gao J-Q. Exosomes as novel bio-carriers for gene and drug delivery. Int J Pharm. 2017;521(1\u20132):167\u201375.","journal-title":"Int J Pharm"},{"issue":"4","key":"1024_CR96","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nbt.1807","volume":"29","author":"L Alvarez-Erviti","year":"2011","unstructured":"Alvarez-Erviti L, Seow Y, Yin H, Betts C, Lakhal S, Wood MJ. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol. 2011;29(4):341\u20135.","journal-title":"Nat Biotechnol"},{"key":"1024_CR97","doi-asserted-by":"publisher","first-page":"6917","DOI":"10.2147\/IJN.S264498","volume":"15","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Bi J, Huang J, Tang Y, Du S, Li P. Exosome: a review of its classification, isolation techniques, storage, diagnostic and targeted therapy applications. Int J Nanomed. 2020;15:6917.","journal-title":"Int J Nanomed"},{"issue":"1","key":"1024_CR98","doi-asserted-by":"publisher","first-page":"237","DOI":"10.7150\/thno.21945","volume":"8","author":"C He","year":"2018","unstructured":"He C, Zheng S, Luo Y, Wang B. Exosome theranostics: biology and translational medicine. Theranostics. 2018;8(1):237.","journal-title":"Theranostics."},{"issue":"1","key":"1024_CR99","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12951-022-01472-z","volume":"20","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Liu Q, Zhang X, Huang H, Tang S, Chai Y, et al. Recent advances in exosome-mediated nucleic acid delivery for cancer therapy. J Nanobiotechnol. 2022;20(1):1\u201329.","journal-title":"J Nanobiotechnol"},{"key":"1024_CR100","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.addr.2020.04.004","volume":"159","author":"OM Elsharkasy","year":"2020","unstructured":"Elsharkasy OM, Nordin JZ, Hagey DW, de Jong OG, Schiffelers RM, Andaloussi SE, Vader P. Extracellular vesicles as drug delivery systems: why and how? Adv Drug Deliv Rev. 2020;159:332\u201343.","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"1024_CR101","first-page":"1","volume":"5","author":"Y Liu","year":"2015","unstructured":"Liu Y, Li D, Liu Z, Zhou Y, Chu D, Li X, et al. Targeted exosome-mediated delivery of opioid receptor Mu siRNA for the treatment of morphine relapse. Sci Rep. 2015;5(1):1\u201310.","journal-title":"Sci Rep"},{"key":"1024_CR102","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118369","volume":"261","author":"E Bagheri","year":"2020","unstructured":"Bagheri E, Abnous K, Farzad SA, Taghdisi SM, Ramezani M, Alibolandi M. Targeted doxorubicin-loaded mesenchymal stem cells-derived exosomes as a versatile platform for fighting against colorectal cancer. Life Sci. 2020;261: 118369.","journal-title":"Life Sci"},{"issue":"2","key":"1024_CR103","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/cgt.2016.77","volume":"24","author":"R Nedaeinia","year":"2017","unstructured":"Nedaeinia R, Manian M, Jazayeri M, Ranjbar M, Salehi R, Sharifi M, et al. Circulating exosomes and exosomal microRNAs as biomarkers in gastrointestinal cancer. Cancer Gene Ther. 2017;24(2):48\u201356.","journal-title":"Cancer Gene Ther"},{"issue":"3","key":"1024_CR104","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.1007\/s11033-021-07007-3","volume":"49","author":"M Salehi","year":"2022","unstructured":"Salehi M, Vafadar A, Khatami SH, Taheri-Anganeh M, Vakili O, Savardashtaki A, et al. Gastrointestinal cancer drug resistance: the role of exosomal miRNAs. Mol Biol Rep. 2022;49(3):2421\u201332.","journal-title":"Mol Biol Rep"},{"issue":"2","key":"1024_CR105","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.gene.2015.08.067","volume":"575","author":"D Xitong","year":"2016","unstructured":"Xitong D, Xiaorong Z. Targeted therapeutic delivery using engineered exosomes and its applications in cardiovascular diseases. Gene. 2016;575(2):377\u201384.","journal-title":"Gene"},{"issue":"4","key":"1024_CR106","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s00018-014-1764-3","volume":"72","author":"LT Brinton","year":"2015","unstructured":"Brinton LT, Sloane HS, Kester M, Kelly KA. Formation and role of exosomes in cancer. Cell Mol Life Sci. 2015;72(4):659\u201371.","journal-title":"Cell Mol Life Sci"},{"key":"1024_CR107","doi-asserted-by":"publisher","first-page":"5753","DOI":"10.2147\/OTT.S173110","volume":"11","author":"H Gomari","year":"2018","unstructured":"Gomari H, Forouzandeh Moghadam M, Soleimani M. Targeted cancer therapy using engineered exosome as a natural drug delivery vehicle. OncoTargets Thera. 2018;11:5753\u201362.","journal-title":"OncoTargets Thera."},{"issue":"4","key":"1024_CR108","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1007\/s00432-021-03520-x","volume":"147","author":"L Jiang","year":"2021","unstructured":"Jiang L, Gong X, Liao W, Lv N, Yan R. Molecular targeted treatment and drug delivery system for gastric cancer. J Cancer Res Clin Oncol. 2021;147(4):973\u201386.","journal-title":"J Cancer Res Clin Oncol"},{"key":"1024_CR109","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.114053","volume":"157","author":"D Wang","year":"2023","unstructured":"Wang D, Li R, Jiang J, Qian H, Xu W. Exosomal circRNAs: novel biomarkers and therapeutic targets for gastrointestinal tumors. Biomed Pharmacother. 2023;157: 114053.","journal-title":"Biomed Pharmacother"},{"issue":"11","key":"1024_CR110","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1166\/jbt.2022.3167","volume":"12","author":"Q Tian","year":"2022","unstructured":"Tian Q, Guo Y, Li D, Dong L. Hybrid gastric cancer exosome as potential drug carrier for targeted gastric cancer therapy. J Biomater Tissue Eng. 2022;12(11):2228\u201332.","journal-title":"J Biomater Tissue Eng."},{"issue":"9","key":"1024_CR111","first-page":"1913","volume":"7","author":"X-W Guan","year":"2017","unstructured":"Guan X-W, Zhao F, Wang J-Y, Wang H-Y, Ge S-H, Wang X, et al. Tumor microenvironment interruption: a novel anti-cancer mechanism of proton-pump inhibitor in gastric cancer by suppressing the release of microRNA-carrying exosomes. Am J Cancer Res. 2017;7(9):1913.","journal-title":"Am J Cancer Res"},{"issue":"1","key":"1024_CR112","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-019-1001-7","volume":"18","author":"M Fu","year":"2019","unstructured":"Fu M, Gu J, Jiang P, Qian H, Xu W, Zhang X. Exosomes in gastric cancer: roles, mechanisms, and applications. Mol Cancer. 2019;18(1):1\u201312.","journal-title":"Mol Cancer"},{"issue":"1","key":"1024_CR113","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-022-03527-z","volume":"20","author":"Z Guo","year":"2022","unstructured":"Guo Z, Zhang Y, Xu W, Zhang X, Jiang J. Engineered exosome-mediated delivery of circDIDO1 inhibits gastric cancer progression via regulation of MiR-1307-3p\/SOCS2 Axis. J Transl Med. 2022;20(1):1\u201315.","journal-title":"J Transl Med"},{"key":"1024_CR114","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113690","volume":"155","author":"NF Hosseini","year":"2022","unstructured":"Hosseini NF, Amini R, Ramezani M, Saidijam M, Hashemi SM, Najafi R. AS1411 aptamer-functionalized exosomes in the targeted delivery of doxorubicin in fighting colorectal cancer. Biomed Pharmacother. 2022;155: 113690.","journal-title":"Biomed Pharmacother"},{"issue":"8","key":"1024_CR115","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1016\/j.drudis.2020.06.027","volume":"25","author":"M Zeinali","year":"2020","unstructured":"Zeinali M, Abbaspour-Ravasjani S, Ghorbani M, Babazadeh A, Soltanfam T, Santos AC, et al. Nanovehicles for co-delivery of anticancer agents. Drug Discov Today. 2020;25(8):1416\u201330.","journal-title":"Drug Discov Today"},{"issue":"10","key":"1024_CR116","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/nmat1737","volume":"5","author":"Y Wang","year":"2006","unstructured":"Wang Y, Gao S, Ye W-H, Yoon HS, Yang Y-Y. Co-delivery of drugs and DNA from cationic core\u2013shell nanoparticles self-assembled from a biodegradable copolymer. Nat Mater. 2006;5(10):791\u20136.","journal-title":"Nat Mater"},{"issue":"7","key":"1024_CR117","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1038\/mt.2014.96","volume":"22","author":"F Alexis","year":"2014","unstructured":"Alexis F. Nano-polypharmacy to treat tumors: coencapsulation of drug combinations using nanoparticle technology. Mol Ther. 2014;22(7):1239\u201340.","journal-title":"Mol Ther"},{"key":"1024_CR118","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.addr.2015.10.021","volume":"98","author":"C He","year":"2016","unstructured":"He C, Tang Z, Tian H, Chen X. Co-delivery of chemotherapeutics and proteins for synergistic therapy. Adv Drug Deliv Rev. 2016;98:64\u201376.","journal-title":"Adv Drug Deliv Rev"},{"key":"1024_CR119","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/j.msec.2016.11.073","volume":"71","author":"SZ Vahed","year":"2017","unstructured":"Vahed SZ, Salehi R, Davaran S, Sharifi S. Liposome-based drug co-delivery systems in cancer cells. Mater Sci Eng, C. 2017;71:1327\u201341.","journal-title":"Mater Sci Eng, C"},{"issue":"2","key":"1024_CR120","first-page":"141","volume":"2","author":"X Wang","year":"2019","unstructured":"Wang X, Zhang H, Chen X. Drug resistance and combating drug resistance in cancer. Cancer Drug Resist (Alhambra, Calif). 2019;2(2):141\u201360.","journal-title":"Cancer Drug Resist (Alhambra, Calif)."},{"key":"1024_CR121","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biomaterials.2018.10.032","volume":"192","author":"X Wan","year":"2019","unstructured":"Wan X, Beaudoin JJ, Vinod N, Min Y, Makita N, Bludau H, et al. Co-delivery of paclitaxel and cisplatin in poly (2-oxazoline) polymeric micelles: Implications for drug loading, release, pharmacokinetics and outcome of ovarian and breast cancer treatments. Biomaterials. 2019;192:1\u201314.","journal-title":"Biomaterials"},{"issue":"7","key":"1024_CR122","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1039\/C4BM00369A","volume":"3","author":"Z Yang","year":"2015","unstructured":"Yang Z, Gao D, Cao Z, Zhang C, Cheng D, Liu J, Shuai X. Drug and gene co-delivery systems for cancer treatment. Biomater Sci. 2015;3(7):1035\u201349.","journal-title":"Biomater Sci"},{"issue":"6","key":"1024_CR123","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1007\/s13346-021-01041-1","volume":"12","author":"S Nezhadi","year":"2022","unstructured":"Nezhadi S, Dorkoosh FA. Co-delivery systems: hope for clinical application? Drug Deliv Transl Res. 2022;12(6):1339\u201354.","journal-title":"Drug Deliv Transl Res"},{"issue":"1","key":"1024_CR124","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1080\/10717544.2022.2094498","volume":"29","author":"B Li","year":"2022","unstructured":"Li B, Shao H, Gao L, Li H, Sheng H, Zhu L. Nano-drug co-delivery system of natural active ingredients and chemotherapy drugs for cancer treatment: a review. Drug Deliv. 2022;29(1):2130\u201361.","journal-title":"Drug Deliv"},{"key":"1024_CR125","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.jconrel.2021.06.034","volume":"336","author":"Y Liang","year":"2021","unstructured":"Liang Y, Liu ZY, Wang PY, Li YJ, Wang RR, Xie SY. Nanoplatform-based natural products co-delivery system to surmount cancer multidrug-resistant. J Controlled Release. 2021;336:396\u2013409.","journal-title":"J Controlled Release."},{"key":"1024_CR126","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.biopha.2018.11.145","volume":"110","author":"S Mahira","year":"2019","unstructured":"Mahira S, Kommineni N, Husain GM, Khan W. Cabazitaxel and silibinin co-encapsulated cationic liposomes for CD44 targeted delivery: a new insight into nanomedicine based combinational chemotherapy for prostate cancer. Biomed Pharmacother. 2019;110:803\u201317.","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"1024_CR127","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.3390\/molecules24061035","volume":"24","author":"J Pan","year":"2019","unstructured":"Pan J, Rostamizadeh K, Filipczak N, Torchilin VP. Polymeric co-delivery systems in cancer treatment: an overview on component drugs\u2019 dosage ratio effect. Molecules. 2019;24(6):1035.","journal-title":"Molecules"},{"issue":"1","key":"1024_CR128","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41556-018-0250-9","volume":"21","author":"M Mathieu","year":"2019","unstructured":"Mathieu M, Martin-Jaular L, Lavieu G, Th\u00e9ry C. Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication. Nat Cell Biol. 2019;21(1):9\u201317.","journal-title":"Nat Cell Biol"},{"issue":"17","key":"1024_CR129","doi-asserted-by":"publisher","first-page":"7889","DOI":"10.7150\/thno.45028","volume":"10","author":"Q Zhan","year":"2020","unstructured":"Zhan Q, Yi K, Qi H, Li S, Li X, Wang Q, et al. Engineering blood exosomes for tumor-targeting efficient gene\/chemo combination therapy. Theranostics. 2020;10(17):7889.","journal-title":"Theranostics."},{"issue":"1","key":"1024_CR130","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12951-019-0560-5","volume":"18","author":"G Liang","year":"2020","unstructured":"Liang G, Zhu Y, Ali DJ, Tian T, Xu H, Si K, et al. Engineered exosomes for targeted co-delivery of miR-21 inhibitor and chemotherapeutics to reverse drug resistance in colon cancer. J Nanobiotechnol. 2020;18(1):1\u201315.","journal-title":"J Nanobiotechnol"},{"issue":"1","key":"1024_CR131","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1002\/jcp.30566","volume":"237","author":"B Hui","year":"2022","unstructured":"Hui B, Lu C, Wang J, Xu Y, Yang Y, Ji H, et al. Engineered exosomes for co-delivery of PGM5-AS1 and oxaliplatin to reverse drug resistance in colon cancer. J Cell Physiol. 2022;237(1):911\u201333.","journal-title":"J Cell Physiol"},{"key":"1024_CR132","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2022.121462","volume":"283","author":"D Zhu","year":"2022","unstructured":"Zhu D, Zhang T, Li Y, Huang C, Suo M, Xia L, et al. Tumor-derived exosomes co-delivering aggregation-induced emission luminogens and proton pump inhibitors for tumor glutamine starvation therapy and enhanced type-I photodynamic therapy. Biomaterials. 2022;283: 121462.","journal-title":"Biomaterials"},{"issue":"3","key":"1024_CR133","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/nri.2017.140","volume":"18","author":"OJ Finn","year":"2018","unstructured":"Finn OJ. The dawn of vaccines for cancer prevention. Nat Rev Immunol. 2018;18(3):183\u201394.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"1024_CR134","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13046-019-1154-7","volume":"38","author":"A Lopes","year":"2019","unstructured":"Lopes A, Vandermeulen G, Pr\u00e9at V. Cancer DNA vaccines: current preclinical and clinical developments and future perspectives. J Exp Clin Cancer Res. 2019;38(1):1\u201324.","journal-title":"J Exp Clin Cancer Res"},{"issue":"4","key":"1024_CR135","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/j.ymthe.2017.01.022","volume":"25","author":"JN Walters","year":"2017","unstructured":"Walters JN, Ferraro B, Duperret EK, Kraynyak KA, Chu J, Saint-Fleur A, et al. A novel DNA vaccine platform enhances neo-antigen-like T cell responses against WT1 to break tolerance and induce anti-tumor immunity. Mol Ther. 2017;25(4):976\u201388.","journal-title":"Mol Ther"},{"issue":"11","key":"1024_CR136","doi-asserted-by":"publisher","first-page":"3605","DOI":"10.3390\/ijms19113605","volume":"19","author":"D Hobernik","year":"2018","unstructured":"Hobernik D, Bros M. DNA vaccines\u2014how far from clinical use? Int J Mol Sci. 2018;19(11):3605.","journal-title":"Int J Mol Sci"},{"key":"1024_CR137","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.coi.2016.11.001","volume":"45","author":"T Kumai","year":"2017","unstructured":"Kumai T, Kobayashi H, Harabuchi Y, Celis E. Peptide vaccines in cancer\u2014old concept revisited. Curr Opin Immunol. 2017;45:1\u20137.","journal-title":"Curr Opin Immunol"},{"issue":"7","key":"1024_CR138","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1080\/13696998.2019.1582059","volume":"22","author":"AE Hay","year":"2019","unstructured":"Hay AE, Cheung MC. CAR T-cells: costs, comparisons, and commentary. J Med Econ. 2019;22(7):613\u20135.","journal-title":"J Med Econ"},{"issue":"6230","key":"1024_CR139","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1126\/science.aaa4967","volume":"348","author":"SA Rosenberg","year":"2015","unstructured":"Rosenberg SA, Restifo NP. Adoptive cell transfer as personalized immunotherapy for human cancer. Science. 2015;348(6230):62\u20138.","journal-title":"Science"},{"issue":"4","key":"1024_CR140","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1172\/JCI81137","volume":"126","author":"JM Pitt","year":"2016","unstructured":"Pitt JM, Andr\u00e9 F, Amigorena S, Soria J-C, Eggermont A, Kroemer G, Zitvogel L. Dendritic cell-derived exosomes for cancer therapy. J Clin Investig. 2016;126(4):1224\u201332.","journal-title":"J Clin Investig"},{"issue":"4","key":"1024_CR141","doi-asserted-by":"publisher","first-page":"E74","DOI":"10.1002\/ijc.29100","volume":"136","author":"X Gu","year":"2015","unstructured":"Gu X, Erb U, B\u00fcchler MW, Z\u00f6ller M. Improved vaccine efficacy of tumor exosome compared to tumor lysate loaded dendritic cells in mice. Int J Cancer. 2015;136(4):E74\u201384.","journal-title":"Int J Cancer"},{"issue":"3","key":"1024_CR142","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/ni1173","volume":"6","author":"M Krogsgaard","year":"2005","unstructured":"Krogsgaard M, Davis MM. How T cells \u201csee\u201d antigen. Nat Immunol. 2005;6(3):239\u201345.","journal-title":"Nat Immunol"},{"issue":"12","key":"1024_CR143","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1038\/ni854","volume":"3","author":"C Th\u00e9ry","year":"2002","unstructured":"Th\u00e9ry C, Duban L, Segura E, V\u00e9ron P, Lantz O, Amigorena S. Indirect activation of na\u00efve CD4+ T cells by dendritic cell-derived exosomes. Nat Immunol. 2002;3(12):1156\u201362.","journal-title":"Nat Immunol"},{"issue":"1","key":"1024_CR144","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.imlet.2012.07.006","volume":"148","author":"A Marton","year":"2012","unstructured":"Marton A, Vizler C, Kusz E, Temesfoi V, Szathmary Z, Nagy K, et al. Melanoma cell-derived exosomes alter macrophage and dendritic cell functions in vitro. Immunol Lett. 2012;148(1):34\u20138.","journal-title":"Immunol Lett"},{"issue":"11","key":"1024_CR145","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1111\/j.1582-4934.2009.00851.x","volume":"14","author":"Y Xie","year":"2010","unstructured":"Xie Y, Bai O, Zhang H, Yuan J, Zong S, Chibbar R, et al. Membrane-bound HSP70-engineered myeloma cell-derived exosomes stimulate more efficient CD8+ CTL-and NK-mediated antitumour immunity than exosomes released from heat-shocked tumour cells expressing cytoplasmic HSP70. J Cell Mol Med. 2010;14(11):2655\u201366.","journal-title":"J Cell Mol Med"},{"issue":"3","key":"1024_CR146","first-page":"205","volume":"3","author":"S Hao","year":"2006","unstructured":"Hao S, Bai O, Yuan J, Qureshi M, Xiang J. Dendritic cell-derived exosomes stimulate stronger CD8+ CTL responses and antitumor immunity than tumor cell-derived exosomes. Cell Mol Immunol. 2006;3(3):205\u201311.","journal-title":"Cell Mol Immunol"},{"issue":"2","key":"1024_CR147","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.canlet.2008.10.021","volume":"275","author":"J-A Cho","year":"2009","unstructured":"Cho J-A, Lee Y-S, Kim S-H, Ko J-K, Kim C-W. MHC independent anti-tumor immune responses induced by Hsp70-enriched exosomes generate tumor regression in murine models. Cancer Lett. 2009;275(2):256\u201365.","journal-title":"Cancer Lett"},{"issue":"7","key":"1024_CR148","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.4161\/onci.20897","volume":"1","author":"S Munich","year":"2012","unstructured":"Munich S, Sobo-Vujanovic A, Buchser WJ, Beer-Stolz D, Vujanovic NL. Dendritic cell exosomes directly kill tumor cells and activate natural killer cells via TNF superfamily ligands. Oncoimmunology. 2012;1(7):1074\u201383.","journal-title":"Oncoimmunology."},{"issue":"1","key":"1024_CR149","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3892\/ol.2015.3155","volume":"10","author":"J Wang","year":"2015","unstructured":"Wang J, Wang Z, Mo Y, Zeng Z, Wei P, Li T. Effect of hyperthermic CO2-treated dendritic cell-derived exosomes on the human gastric cancer AGS cell line. Oncol Lett. 2015;10(1):71\u20136.","journal-title":"Oncol Lett"},{"issue":"4","key":"1024_CR150","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1038\/mt.2008.1","volume":"16","author":"S Dai","year":"2008","unstructured":"Dai S, Wei D, Wu Z, Zhou X, Wei X, Huang H, Li G. Phase I clinical trial of autologous ascites-derived exosomes combined with GM-CSF for colorectal cancer. Mol Ther. 2008;16(4):782\u201390.","journal-title":"Mol Ther"},{"issue":"4","key":"1024_CR151","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.jhep.2017.05.019","volume":"67","author":"Z Lu","year":"2017","unstructured":"Lu Z, Zuo B, Jing R, Gao X, Rao Q, Liu Z, et al. Dendritic cell-derived exosomes elicit tumor regression in autochthonous hepatocellular carcinoma mouse models. J Hepatol. 2017;67(4):739\u201348.","journal-title":"J Hepatol"},{"key":"1024_CR152","unstructured":"Leah K Miller Mea. https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT03874559."},{"key":"1024_CR153","unstructured":"https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT05427227."},{"key":"1024_CR154","unstructured":"Jarnagin W. https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT02393703."},{"key":"1024_CR155","unstructured":"https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT04394572."},{"key":"1024_CR156","unstructured":"https:\/\/www.clinicaltrials.gov\/study\/NCT04227886."},{"key":"1024_CR157","unstructured":"https:\/\/www.clinicaltrials.gov\/study\/NCT03821909."},{"key":"1024_CR158","unstructured":"https:\/\/www.clinicaltrials.gov\/study\/NCT01779583."},{"key":"1024_CR159","unstructured":"https:\/\/www.clinicaltrials.gov\/study\/NCT03581435."},{"key":"1024_CR160","unstructured":"https:\/\/www.clinicaltrials.gov\/study\/NCT04852653."},{"key":"1024_CR161","unstructured":"https:\/\/www.clinicaltrials.gov\/study\/NCT04523389."},{"key":"1024_CR162","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/s43856-022-00088-6","volume":"2","author":"JP Hinestrosa","year":"2022","unstructured":"Hinestrosa JP, Kurzrock R, Lewis JM, Schork NJ, Schroeder G, Kamat AM, et al. Early-stage multi-cancer detection using an extracellular vesicle protein-based blood test. Commun Med. 2022;2:29.","journal-title":"Commun Med"},{"key":"1024_CR163","unstructured":"https:\/\/www.clinicaltrials.gov\/study\/NCT03711890."},{"key":"1024_CR164","unstructured":"https:\/\/www.clinicaltrials.gov\/study\/NCT05575622."},{"key":"1024_CR165","unstructured":"https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT06278064."},{"key":"1024_CR166","unstructured":"Gerald W. Dryden J. https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT01294072."},{"issue":"5","key":"1024_CR167","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202002777RR","volume":"35","author":"M Tang","year":"2021","unstructured":"Tang M, Chen Y, Li B, Sugimoto H, Yang S, Yang C, et al. Therapeutic targeting of STAT3 with small interference RNAs and antisense oligonucleotides embedded exosomes in liver fibrosis. FASEB J. 2021;35(5): e21557.","journal-title":"FASEB J"},{"key":"1024_CR168","unstructured":"https:\/\/www.clinicaltrials.gov\/study\/NCT05375604."}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-024-01024-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-024-01024-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-024-01024-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T05:19:02Z","timestamp":1715663942000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-024-01024-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,14]]},"references-count":168,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1024"],"URL":"https:\/\/doi.org\/10.1007\/s12672-024-01024-x","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,14]]},"assertion":[{"value":"19 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"162"}}